FDA’s FY 2013 Drug GMP Warning Letters
This article was originally published in The Gold Sheet
Executive Summary
Topicals and injectables were the most common types of products to receive drug GMP warning letters in FY 2013. All 43 warning letters are listed here by dosage form with the key issues described.